Does the response to cocaine differ as a function of sex or hormonal status in human and non-human primates?

Hormones and Behavior

Volumn 58, Issue 1, 2010, Pages 13-21

  Evans, Suzette M ^a   Foltin, Richard W ^a  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Cocaine; Estradiol; Humans; Menstrual cycle; Non human primates; Pharmacokinetics; Progesterone; Self administration; Sex differences; Subjective response

Indexed keywords

COCAINE; PLACEBO; PROGESTERONE; DOPAMINE UPTAKE INHIBITOR; HORMONE;

ARTICLE; CLINICAL TRIAL; COCAINE DEPENDENCE; ESTRUS CYCLE; FOLLICULAR PHASE; HORMONE ACTION; HUMAN; LUTEAL PHASE; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; RHESUS MONKEY; SEX DIFFERENCE; ANIMAL; DRUG EFFECTS; METABOLISM; PATHOPHYSIOLOGY; PRIMATE; SEXUAL DEVELOPMENT;

ANIMALS; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE UPTAKE INHIBITORS; HORMONES; HUMANS; MENSTRUAL CYCLE; PRIMATES; SEX CHARACTERISTICS;

EID: 77953479421     PISSN: 0018506X     EISSN: 10956867     Source Type: Journal    
DOI: 10.1016/j.yhbeh.2009.08.010     Document Type: Article

References (73)

1. Allen S.S., Hatsukami D., Christianson D., Brown S. Effects of transdermal nicotine on craving, withdrawal and premenstrual symptomatology in short-term smoking abstinence during different phases of the menstrual cycle. Nicotine Tob. Res. 2000, 2:231-241.
2. Anker J.J., Larson E.B., Glidden L.A., Carroll M.E. Effects of progesterone on the reinstatement of cocaine-seeking behavior in female rats. Exp. Clin. Psychopharmacol. 2007, 15:472-480.
3. Becker J.B., Molenda H., Hummer D.L. Gender differences in the behavioral responses to cocaine and amphetamine. Ann. N. Y. Acad. Sci. 2001, 937:172-187.
4. Borrelli B., Papandonatos G., Spring B., Hitsman B., Niaura R. Experimenter-defined quit dates for smoking cessation: adherence improves outcomes for women but not for men. Addiction 2004, 99:378-385.
5. Bowman B.P., Vaughn S.R., Walker Q.D., Davis S.L., Little P.J., Scheffler N.M., Thomas B.F., Kuhn C.M. Effects of sex and gonadectomy on cocaine metabolism in the rat. J. Pharmacol. Exp. Ther. 1999, 290:1316-1323.
6. Butcher R.L., Collins W.E., Fugo N.W. Plasma concentrations of LH, FSH, prolactin, progesterone and estradiol-17β throughout the 4-day estrous cycle of the rat. Endocrinology 1974, 94:1704-1708.
7. Cain S.B., Bowen C.A., Yu G., Zuzga Dd., Negus S.S., Mello N.K. Effect of gonadectomy and gonadal hormone replacement on cocaine self-administration in female and male rats. Neuropsychopharmacology 2004, 29:929-942.
8. Carroll M.E., Morgan A.D., Campbell U.C., Lynch W.J., Dess N.K. Influence of estrogen in the acquisition of intravenously self-administration in rats selectively bred for differential saccharin intake: phenotype and sex differences. Psychopharmacology 2002, 161:304-313.
9. Carroll M.E., Lynch W.J., Roth M.E., Morgan A.D., Cosgrove K.P. Sex and estrogen influence drug abuse. Trends Pharmacol. Sci. 2004, 25:273-279.
10. Chen C.J., Vandenbergh J.G. Effect of chronic cocaine on reproduction in female house mice. Pharmacol. Biochem. Behav. 1994, 48:909-913.
11. Collins S.L., Evans S.M., Foltin R.W., Haney M. Intranasal cocaine in humans: effects of sex and menstrual cycle. Pharmacol. Biochem. Behav. 2007, 86:117-124.
12. Evans S.M. The role of estradiol and progesterone in modulating the subjective effects of stimulants in humans. Exp. Clin. Psychopharmacology 2007, 15:418-426.
13. Evans S.M., Foltin R.W. Pharmacokinetics of intravenous cocaine across the menstrual cycle in rhesus monkeys. Neuropsychopharmacology 2004, 29:1889-1900.
14. Evans S.M., Foltin R.W. Exogenous progesterone attenuates the subjective effects of smoked cocaine in women, but not in men. Neuropsychopharmacology 2006, 31:659-674.
15. Evans S.M., Foltin R.W. Pharmacokinetics of repeated doses of intravenous cocaine across the menstrual cycle in rhesus monkeys. Pharmacol. Biochem. Behav. 2006, 83:56-66.
16. Evans S.M., Haney M., Fischman M.W., Foltin R.W. Limited sex differences in response to binge smoked cocaine use in humans. Neuropsychopharmacology 1999, 21:445-454.
17. Evans S.M., Haney M., Foltin R.W. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology 2002, 159:397-406.
18. Feltenstein M.W., See R.E. Plasma progesterone levels and cocaine-seeking in freely cycling female rats across the estrous cycle. Drug Alcohol Depend. 2007, 89:183-189.
19. Feltenstein M.W., Byrd E.A., Henderson A.R., See R.E. Attenuation of cocaine-seeking by progesterone treatment in female rats. Psychoneuroendocrinology 2009, 34:343-352.
20. Festa E.D., Quiñones-Jenab V. Gonadal hormones provide the biological basis for sex differences in behavioral responses to cocaine. Horm. Behav. 2004, 46:509-519.
21. Festa E.D., Russo S.J., Gazi F.M., Niyomchai T., Kemen L.M., Lin S.N., Foltz R., Jenab S., Quiñones-Jenab V. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 2004, 46:672-687.
22. Foltin R.W., Haney M. Intranasal cocaine in humans: acute tolerance, cardiovascular, and subjective effects. Pharmacol. Biochem. Behav. 2004, 78:93-101.
23. Haney M., Spealman R. Controversies in translational research: drug self-administration. Psychopharmacology 2008, 199:403-419.
24. Haney M., Foltin R.W., Fischman M.W. Effects of pergolide on intravenous cocaine self-administration in men and women. Psychopharmacology 1998, 137:15-24.
25. Hecht G.S., Spear N.E., Spear L.P. Changes in progressive ratio responding for intravenous cocaine throughout the reproductive process in female rats. Dev. Psychobiol. 1999, 35:136-145.
26. Hodos W. Progressive ratio as a measure of reward strength. Science 1961, 134:943-944.
27. Hyman S.M., Paliwal P., Chaplin T.M., Mazure C.M., Rounsaville B.J., Sinha R. Severity of childhood trauma is predictive of cocaine relapse outcomes in women but not men. Drug Alcohol Depend. 2008, 92:208-216.
28. Jackson L.R., Robinson T.E., Becker J.B. Sex differences and hormonal influences on acquisition of cocaine self-administration in rats. Neuropsychopharmacology 2006, 31:129-138.
29. Justice A.J.H., de Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol. Biochem. Behav. 2000, 66:509-515.
30. Justice A.J.H., de Wit H. Acute effects of estradiol pretreatment on the response to d-amphetamine in women. Neuroendocrinology 2000, 71:51-59.
31. King T.S., Canez M.S., Gaskill S., Javors M.A., Schenken R.S. Chronic cocaine disruption of estrous cyclicity in the rat: dose-dependent effects. J. Pharmacol. Exp. Ther. 1993, 264:29-34.
32. King A., de Wit H., Riley R.C., Cao D., Niaura R., Hatsukami D. Efficacy of naltrexone in smoking cessation: a preliminary study and an examination of sex differences. Nicotine Tob. Res. 2006, 8:671-682.
33. Kosten T.R., Kosten T.A., McDougle C.J., Hameedi F.A., McCance E.F., Rosen M.I., Oliveto A.H., Price L.H. Gender differences in response to intranasal cocaine administration to humans. Biological. Psychiatry 1996, 39:147-148.
34. Larson E.B., Anker J.J., Gliddon L.A., Fons K.S., Carroll M.E. Effects of estrogen and progesterone on the escalation of cocaine self-administration in female rats during extended access. Exp. Clin. Psychopharmacol. 2007, 15:461-471.
35. Lile J.A., Kendall S.L., Babalonis S., Martin C.A., Kelly T.H. Evaluation of estradiol administration on the discriminative-stimulus and subject-rated effects of d-amphetamine in healthy pre-menopausal women. Pharmacol. Biochem. Behav. 2007, 87:258-266.
36. Lukas S.E., Sholar M., Hundahl L.H., Lamas X., Kouri E., Wines J.D., Kragie L., Mendelson J.H. Sex differences in plasma cocaine levels and subjective effects after acute cocaine administration in human volunteers. Psychopharmacology 1996, 125:346-354.
37. Lynch W.J., Roth M.N., Carroll M.E. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 2002, 164:121-137.
38. Lynch W.J., Kalayasiri R., Sughondhabirom A., Pittman B., Coric V., Morgan P.T., Malison R.T. Subjective responses and cardiovascular effects of self-administered cocaine in cocaine-abusing men and women. Addict. Biol. 2008, 13:403-410.
39. McCance-Katz E.F., Carroll K.M., Rounsaville B.J. Gender differences in treatment-seeking cocaine abusers-implications for treatment and prognosis. Am. J. Addict. 1999, 8:300-311.
40. Mello N.K. Cocaine abuse and reproductive function in women. Drug Addiction Research and the Health of Women 1998, 131-149. U.S. Government Printing Office, Washington, DC. C.L. Wetherington, A.B. Roman (Eds.).
41. Mello N.K., Mendelson J.H. Cocaine, hormones, and behavior: clinical and preclinical studies. Horm. Brain Behav. 2002, 5:665-745.
42. Mello N.K., Sarnyai Z., Mendelson J.H., Drieze J.M., Kelly M. Acute effects of cocaine on anterior pituitary hormones in male and female rhesus monkeys. J. Pharmacol. Exp. Ther. 1993, 266:804-811.
43. Mello N.K., Mendelson J.H., Kelly M., Diaz-Migoyo N., Sholar J.W. The effects of chronic cocaine self-administration on the menstrual cycle in rhesus monkeys. J. Pharmacol. Exp. Ther. 1997, 281:70-83.
44. Mello N.K., Mendelson J.H., Kelly M., Bowen C. The effects of cocaine on basal and human chorionic gonadotropin-stimulated ovarian steroid hormones in female rhesus monkeys. J. Pharmacol. Exp. Ther. 2000, 294:1137-1145.
45. Mello N.K., Bowen C.A., Mendelson J.H. Comparison of plasma cocaine levels during a "binge" pattern of cocaine administration in male and female rhesus monkeys. Psychopharmacology 2002, 164:19-26.
46. Mello N.K., Knudson I.M., Mendelson J.H. Sex and menstrual cycle effects on progressive ratio measures of cocaine self-administration in cynomolgus monkeys. Neuropsychopharmacology 2007, 32:1956-1966.
47. Mello N.K., Negus S.S., Knudson I.M., Kelly M., Mendelson J.H. Effects of estradiol on cocaine self-administration and cocaine discrimination by female rhesus monkeys. Neuropsychopharmacology 2008, 33:783-795.
48. Mendelson J.H., Mello N.K., Sholar M.B., Siegel A.J., Kaufman M.J., Levin J.M., Renshaw P.F., Cohen B.M. Cocaine pharmacokinetics in men and in women during the follicular and luteal phases of the menstrual cycle. Neuropsychopharmacology 1999, 21:294-303.
49. Mendelson J.H., Mello N.K., Negus S.S. Effects of luteinizing hormone-releasing hormone on plasma cocaine levels in rhesus monkeys. J. Pharmacol. Exp. Ther. 1999, 289:791-799.
50. Najavits L.M., Lester K.M. Gender differences in cocaine dependence. Drug Alcohol Depend. 2008, 97:190-194.
51. Niyomchai T., Akhavan A., Festa E.D., Lin S-N., Lamm L., Foltz R., Quiñones-Jenab V. Estrogen and progesterone affect cocaine pharmacokinetics in female rats. Brain Res. Bull. 2006, 68:310-314.
52. O'Brien M.S., Anthony J.C. Risk of becoming cocaine dependent: epidemiological estimates for the United States, 2000-2001. Neuropsychopharmacology 2005, 30:1006-1018.
53. Potter D.A., Luther M.F., Eddy C.A., Siler-Khodr T.M., King T.S., Schenken R.S. Low-dose follicular-phase cocaine administration disrupts menstrual cycle and ovarian cyclicity in rhesus monkeys. J. Soc. Gynecol. Invest. 1999, 6:88-94.
54. Quiñones-Jenab V., Perrotti L.I., Mc Monagle J., Ho A., Kreek M.J. Ovarian hormone replacement affects cocaine-induced behaviors in ovariectomized female rats. Pharmacol. Biochem. Behav. 2000, 67:417-422.
55. Reed, S.C., Levin, F.R., Evans, S.M., 2009. The effects of progesterone pretreatment on the response to oral d-amphetamine: impulsivity, mood and performance. Poster presented at the 2009 Annual College on Problems of Drug Dependence, Reno, NV.
56. Roberts D.C.S., Bennett S.A.L., Vickers G.J. The estrous cycle affects cocaine self-administration on a progressive ratio schedule in rats. Psychopharmacology 1989, 98:408-411.
57. Roth M.E., Cosgrove K.P., Carroll M.E. Sex differences in the vulnerability to drug abuse: a review of preclinical studies. Neurosci. Biobehav. Rev. 2004, 28:533-546.
58. Russo S.J., Festa E.D., Fabian S.J., Gazi F.M., Kraisch M., Jenab S., Quiñones-Jenab V. Gonadal hormones differentially modulate cocaine-induced place preference in male and female rats. Neuroscience 2003, 120:523-533.
59. Saady J.J., Bowman E.R., Aceto M.D. Cocaine, ecgonine methyl ester, and benzoylecgonine plasma profiles in rhesus monkeys. J. Anal. Toxicol. 1995, 19:571-575.
60. Substance Abuse and Mental Health Services Administration, 2008. Results for the 2007 National Survey on Drug Use and Health: National Findings (Office of Applied Studies, NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD.
61. Sell S.L., Scalzitti J.M., Thomas M.L., Cunningham K.A. Influence of ovarian hormones and estrous cycle on the behavioral responses to cocaine in female rats. J. Pharmacol. Exp. Ther. 2000, 293:879-886.
62. Shimizu K. Reproductive hormones and ovarian cycle in macaques. J. Mamm. Ova. Res. 2008, 25:122-126.
63. Sinha R., Rounsaville B.J. Sex differences in depressed substance abusers. J. Clin. Psychiatry 2002, 63:616-627.
64. Siqueland L., Crits-Christoph P, Gallop R., Barber J.P., Griffin M.L., Thase M.E., Daley D.R., Blaine J., Connolly M.B., Gladis M. Retention in psychosocial treatment of cocaine dependence: predictors and impact of outcome. Am. J. Addict. 2002, 11:24-40.
65. Smith M.S., Freeman M.E., Neill J.D. The control of progesterone secretion during the estrous cycle and early pseudopregnancy in the rat: prolactin, gondadotropin and steroid levels associated with rescue of the corpus luteum of pseudopregnancy. Neuroendocrinology 1975, 96:219-226.
66. Sofuoglu M., Dudish-Poulsen S., Nelson D., Pentel P.R., Hatsukami D.K. Sex and menstrual cycle differences in the subjective effects from smoked cocaine in humans. Exp. Clin. Psychopharmacol. 1999, 7:274-283.
67. Sofuoglu M., Babb D.A., Hatsukami D.K. Effects of progesterone treatment on smoked cocaine response in women. Pharmacol. Biochem. Behav. 2002, 72:431-435.
68. Sofuoglu M., Mitchell E., Kosten T.R. Effects of progesterone treatment on cocaine responses in male and female cocaine users. Pharmacol. Biochem. Behav. 2004, 78:699-705.
69. Sofuoglu M., Poling J., Gonzalez G., Gonsai K., Oliveto A., Kosten T.R. Progesterone effects on cocaine use in cocaine users maintained on methadone: a randomized, double-blind clinical trial. Exp. Clin. Psychopharmacol. 2007, 15:453-460.
70. Van Haaren F., Garcea M., Anderson K., Tebbett I. Cocaine and benzoylecgonine in serum microsamples of intact and gonadectomized male and female Wistar rats. Pharmacol. Biochem. Behav. 1997, 58:421-424.
71. White T.L., Justice A.J., de Wit H. Differential subjective effects of d-amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 2002, 73:729-741.
72. Wojnicki F.H., Bacher J.D., Glowa J.R. Use of subcutaneous vascular access ports in rhesus monkeys. Lab. Anim. Sci. 1994, 44:491-494.
73. Yosida T. Similarities and differences in reproductive endocrinology between non-human primates and humans. Cong. Anom. 1999, 39:209-222.